Evaluating Press Releases Before Buying Biotech Stocks
Filed in archive Corporate and Industrial News on January 22, 2007
Investing in biotech stocks requires more than just financial know-how; one has understand a bit of the science behind the companies and products.
Biotech companies issue press releases all the time touting the potential of their experimental drugs, and the stocks move as a result.
But how do you separate the truth from the hype? What sort of questions should you be asking yourself when you evaluate these press releases? And where can you find the unbiased information you need?
Adam Feuerstein offers valuable insights in interpreting press releases, taking Point Therapeutics' press release as a case in point.
But how do you separate the truth from the hype? What sort of questions should you be asking yourself when you evaluate these press releases? And where can you find the unbiased information you need?
Tags: stocks investing biotech press+release press press+releases biotech+stocks releases+before
Vote for Evaluating Press Releases Before Buying Biotech Stocks:
|
Rating: 7.00 out of 1 vote(s) cast.
|
Response from:
KT
(01/22/07 4:59am)
I think you have an excellent, well articulated point in your article
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells